Global Immune-Mediated Inflammatory Diseases Treatment Market Research Report 2024(Status and Outlook)
Report Overview
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.
This report provides a deep insight into the global Immune-Mediated Inflammatory Diseases Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune-Mediated Inflammatory Diseases Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune-Mediated Inflammatory Diseases Treatment market in any manner.
Global Immune-Mediated Inflammatory Diseases Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Market Segmentation (by Type)
Targeted biologic therapies
Novel therapies
Market Segmentation (by Application)
Hospitals
Pharmacy Store
Online Pharmacy Stroe
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune-Mediated Inflammatory Diseases Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.
This report provides a deep insight into the global Immune-Mediated Inflammatory Diseases Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune-Mediated Inflammatory Diseases Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune-Mediated Inflammatory Diseases Treatment market in any manner.
Global Immune-Mediated Inflammatory Diseases Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Market Segmentation (by Type)
Targeted biologic therapies
Novel therapies
Market Segmentation (by Application)
Hospitals
Pharmacy Store
Online Pharmacy Stroe
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Immune-Mediated Inflammatory Diseases Treatment Market
- Overview of the regional outlook of the Immune-Mediated Inflammatory Diseases Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune-Mediated Inflammatory Diseases Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Immune-Mediated Inflammatory Diseases Treatment
1.2 Key Market Segments
1.2.1 Immune-Mediated Inflammatory Diseases Treatment Segment by Type
1.2.2 Immune-Mediated Inflammatory Diseases Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Immune-Mediated Inflammatory Diseases Treatment Sales by Manufacturers (2019-2024)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immune-Mediated Inflammatory Diseases Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immune-Mediated Inflammatory Diseases Treatment Sales Sites, Area Served, Product Type
3.6 Immune-Mediated Inflammatory Diseases Treatment Market Competitive Situation and Trends
3.6.1 Immune-Mediated Inflammatory Diseases Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immune-Mediated Inflammatory Diseases Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Immune-Mediated Inflammatory Diseases Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2019-2024)
6.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Immune-Mediated Inflammatory Diseases Treatment Price by Type (2019-2024)
7 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Sales by Application (2019-2024)
7.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Immune-Mediated Inflammatory Diseases Treatment Sales Growth Rate by Application (2019-2024)
8 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Immune-Mediated Inflammatory Diseases Treatment Sales by Region
8.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Sales by Region
8.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Immune-Mediated Inflammatory Diseases Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immune-Mediated Inflammatory Diseases Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immune-Mediated Inflammatory Diseases Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.1.2 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Eli Lilly
9.2.1 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.2.2 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.2.4 Eli Lilly Business Overview
9.2.5 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
9.2.6 Eli Lilly Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.3.2 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.3.4 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Bristol-Myers
9.4.1 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.4.2 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.4.4 Bristol-Myers Business Overview
9.4.5 Bristol-Myers Recent Developments
9.5 Sanofi
9.5.1 Sanofi Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.5.2 Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Recent Developments
9.6 Roche
9.6.1 Roche Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.6.2 Roche Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Enlivex Therapeutics
9.7.1 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.7.2 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.7.4 Enlivex Therapeutics Business Overview
9.7.5 Enlivex Therapeutics Recent Developments
9.8 Immune Pharmaceuticals
9.8.1 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.8.2 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.8.4 Immune Pharmaceuticals Business Overview
9.8.5 Immune Pharmaceuticals Recent Developments
9.9 Tanabe Pharma
9.9.1 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.9.2 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.9.4 Tanabe Pharma Business Overview
9.9.5 Tanabe Pharma Recent Developments
10 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET FORECAST BY REGION
10.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast
10.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Region
10.2.4 South America Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immune-Mediated Inflammatory Diseases Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immune-Mediated Inflammatory Diseases Treatment by Type (2025-2030)
11.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immune-Mediated Inflammatory Diseases Treatment by Type (2025-2030)
11.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) Forecast by Application
11.2.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Immune-Mediated Inflammatory Diseases Treatment
1.2 Key Market Segments
1.2.1 Immune-Mediated Inflammatory Diseases Treatment Segment by Type
1.2.2 Immune-Mediated Inflammatory Diseases Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Immune-Mediated Inflammatory Diseases Treatment Sales by Manufacturers (2019-2024)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immune-Mediated Inflammatory Diseases Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immune-Mediated Inflammatory Diseases Treatment Sales Sites, Area Served, Product Type
3.6 Immune-Mediated Inflammatory Diseases Treatment Market Competitive Situation and Trends
3.6.1 Immune-Mediated Inflammatory Diseases Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immune-Mediated Inflammatory Diseases Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Immune-Mediated Inflammatory Diseases Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2019-2024)
6.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Immune-Mediated Inflammatory Diseases Treatment Price by Type (2019-2024)
7 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Sales by Application (2019-2024)
7.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Immune-Mediated Inflammatory Diseases Treatment Sales Growth Rate by Application (2019-2024)
8 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Immune-Mediated Inflammatory Diseases Treatment Sales by Region
8.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Sales by Region
8.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Immune-Mediated Inflammatory Diseases Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immune-Mediated Inflammatory Diseases Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immune-Mediated Inflammatory Diseases Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.1.2 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Eli Lilly
9.2.1 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.2.2 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.2.4 Eli Lilly Business Overview
9.2.5 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
9.2.6 Eli Lilly Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.3.2 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.3.4 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Bristol-Myers
9.4.1 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.4.2 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.4.4 Bristol-Myers Business Overview
9.4.5 Bristol-Myers Recent Developments
9.5 Sanofi
9.5.1 Sanofi Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.5.2 Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Recent Developments
9.6 Roche
9.6.1 Roche Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.6.2 Roche Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Enlivex Therapeutics
9.7.1 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.7.2 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.7.4 Enlivex Therapeutics Business Overview
9.7.5 Enlivex Therapeutics Recent Developments
9.8 Immune Pharmaceuticals
9.8.1 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.8.2 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.8.4 Immune Pharmaceuticals Business Overview
9.8.5 Immune Pharmaceuticals Recent Developments
9.9 Tanabe Pharma
9.9.1 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Basic Information
9.9.2 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Overview
9.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Market Performance
9.9.4 Tanabe Pharma Business Overview
9.9.5 Tanabe Pharma Recent Developments
10 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET FORECAST BY REGION
10.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast
10.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Region
10.2.4 South America Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immune-Mediated Inflammatory Diseases Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immune-Mediated Inflammatory Diseases Treatment by Type (2025-2030)
11.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immune-Mediated Inflammatory Diseases Treatment by Type (2025-2030)
11.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) Forecast by Application
11.2.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immune-Mediated Inflammatory Diseases Treatment Market Size Comparison by Region (M USD)
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2022)
Table 10. Global Market Immune-Mediated Inflammatory Diseases Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Immune-Mediated Inflammatory Diseases Treatment Sales Sites and Area Served
Table 12. Manufacturers Immune-Mediated Inflammatory Diseases Treatment Product Type
Table 13. Global Immune-Mediated Inflammatory Diseases Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immune-Mediated Inflammatory Diseases Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immune-Mediated Inflammatory Diseases Treatment Market Challenges
Table 22. Global Immune-Mediated Inflammatory Diseases Treatment Sales by Type (K Units)
Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (M USD)
Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Type (2019-2024)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) by Application
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
Table 31. Global Immune-Mediated Inflammatory Diseases Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Immune-Mediated Inflammatory Diseases Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2019-2024)
Table 35. Global Immune-Mediated Inflammatory Diseases Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Immune-Mediated Inflammatory Diseases Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Immune-Mediated Inflammatory Diseases Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Immune-Mediated Inflammatory Diseases Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Immune-Mediated Inflammatory Diseases Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales by Region (2019-2024) & (K Units)
Table 43. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 44. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 45. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 50. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 51. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
Table 54. Eli Lilly Recent Developments
Table 55. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 56. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 57. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 62. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 63. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Business Overview
Table 65. Bristol-Myers Recent Developments
Table 66. Sanofi Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 67. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 68. Sanofi Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sanofi Business Overview
Table 70. Sanofi Recent Developments
Table 71. Roche Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 72. Roche Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 73. Roche Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 77. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 78. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Enlivex Therapeutics Business Overview
Table 80. Enlivex Therapeutics Recent Developments
Table 81. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 82. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 83. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Immune Pharmaceuticals Business Overview
Table 85. Immune Pharmaceuticals Recent Developments
Table 86. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 87. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 88. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Tanabe Pharma Business Overview
Table 90. Tanabe Pharma Recent Developments
Table 91. Global Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Immune-Mediated Inflammatory Diseases Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immune-Mediated Inflammatory Diseases Treatment Market Size Comparison by Region (M USD)
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2022)
Table 10. Global Market Immune-Mediated Inflammatory Diseases Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Immune-Mediated Inflammatory Diseases Treatment Sales Sites and Area Served
Table 12. Manufacturers Immune-Mediated Inflammatory Diseases Treatment Product Type
Table 13. Global Immune-Mediated Inflammatory Diseases Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immune-Mediated Inflammatory Diseases Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immune-Mediated Inflammatory Diseases Treatment Market Challenges
Table 22. Global Immune-Mediated Inflammatory Diseases Treatment Sales by Type (K Units)
Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (M USD)
Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Type (2019-2024)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) by Application
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
Table 31. Global Immune-Mediated Inflammatory Diseases Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Immune-Mediated Inflammatory Diseases Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2019-2024)
Table 35. Global Immune-Mediated Inflammatory Diseases Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Immune-Mediated Inflammatory Diseases Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Immune-Mediated Inflammatory Diseases Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Immune-Mediated Inflammatory Diseases Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Immune-Mediated Inflammatory Diseases Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales by Region (2019-2024) & (K Units)
Table 43. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 44. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 45. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 50. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 51. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
Table 54. Eli Lilly Recent Developments
Table 55. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 56. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 57. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 62. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 63. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Business Overview
Table 65. Bristol-Myers Recent Developments
Table 66. Sanofi Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 67. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 68. Sanofi Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sanofi Business Overview
Table 70. Sanofi Recent Developments
Table 71. Roche Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 72. Roche Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 73. Roche Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 77. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 78. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Enlivex Therapeutics Business Overview
Table 80. Enlivex Therapeutics Recent Developments
Table 81. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 82. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 83. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Immune Pharmaceuticals Business Overview
Table 85. Immune Pharmaceuticals Recent Developments
Table 86. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Basic Information
Table 87. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Overview
Table 88. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Tanabe Pharma Business Overview
Table 90. Tanabe Pharma Recent Developments
Table 91. Global Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Immune-Mediated Inflammatory Diseases Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Immune-Mediated Inflammatory Diseases Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD), 2019-2030
Figure 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (M USD)
Figure 11. Immune-Mediated Inflammatory Diseases Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Manufacturers in 2023
Figure 13. Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immune-Mediated Inflammatory Diseases Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type
Figure 18. Sales Market Share of Immune-Mediated Inflammatory Diseases Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Immune-Mediated Inflammatory Diseases Treatment by Type in 2023
Figure 20. Market Size Share of Immune-Mediated Inflammatory Diseases Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Immune-Mediated Inflammatory Diseases Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application
Figure 24. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application in 2023
Figure 26. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2019-2024)
Figure 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application in 2023
Figure 28. Global Immune-Mediated Inflammatory Diseases Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Immune-Mediated Inflammatory Diseases Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country in 2023
Figure 37. Germany Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region in 2023
Figure 44. China Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (K Units)
Figure 50. South America Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Immune-Mediated Inflammatory Diseases Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Immune-Mediated Inflammatory Diseases Treatment Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Immune-Mediated Inflammatory Diseases Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD), 2019-2030
Figure 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (M USD)
Figure 11. Immune-Mediated Inflammatory Diseases Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Manufacturers in 2023
Figure 13. Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immune-Mediated Inflammatory Diseases Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type
Figure 18. Sales Market Share of Immune-Mediated Inflammatory Diseases Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Immune-Mediated Inflammatory Diseases Treatment by Type in 2023
Figure 20. Market Size Share of Immune-Mediated Inflammatory Diseases Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Immune-Mediated Inflammatory Diseases Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application
Figure 24. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Application in 2023
Figure 26. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2019-2024)
Figure 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application in 2023
Figure 28. Global Immune-Mediated Inflammatory Diseases Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Immune-Mediated Inflammatory Diseases Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Immune-Mediated Inflammatory Diseases Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country in 2023
Figure 37. Germany Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region in 2023
Figure 44. China Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (K Units)
Figure 50. South America Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Immune-Mediated Inflammatory Diseases Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Immune-Mediated Inflammatory Diseases Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Immune-Mediated Inflammatory Diseases Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Immune-Mediated Inflammatory Diseases Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Immune-Mediated Inflammatory Diseases Treatment Market Share Forecast by Application (2025-2030)
